Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.

Claire Bridel; Cyra E. Leurs; Zoë Y.G.J. van Lierop; Zoé L.E. van Kempen; Iris Dekker; Harry Twaalfhoven; B. Moraal; Frederik Barkhof; Bernard M. J. Uitdehaag; Joep Killestein; Charlotte E. Teunissen

doi:https://doi.org/10.1212/wnl.0000000000012752

doi.org/10.1212/wnl.0000000000012752

Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.

,

,

..., Charlotte E. Teunissen

69

Neurology9.90

Volume: 97, Issue: 19

Published: Sep 9, 2021

Abstract

BACKGROUND AND OBJECTIVES To investigate the potential of serum neurofilament light (NfL) to reflect or predict progression mostly independent of acute inflammatory disease activity in patients with relapsing-remitting multiple sclerosis (RRMS) treated with natalizumab. METHODS Patients were selected from a prospective observational cohort study initiated in 2006 at the VU University Medical Center Amsterdam, the Netherlands, including patients...

Paper Fields

Paper Details

Title

Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.

DOI

doi.org/10.1212/wnl.0000000000012752

Published Date

Sep 9, 2021

Journal

Neurology

Volume

97

Issue

19

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History